Career history of Danute M. Bankaitis-Davis
Former positions of Danute M. Bankaitis-Davis
| Companies | Position | Start | End |
|---|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/01/1992 | 01/01/1998 |
| Syntex Corp. | Corporate Officer/Principal | - | - |
Source Precision Medicine, Inc.
 Source Precision Medicine, Inc. Medical SpecialtiesHealth Technology Source Precision Medicine, Inc. develops and commercializes diagnostic biomarker panels. It develops an integrated molecular diagnostic system, which includes quantitative polymerase chain reaction assays, target specific gene expression ranges, and latent class and proprietary enumeration methodologies that measure vital signs of the cell. Its assays and tests measure RNA-transcript-based gene expression in whole blood using quantitative polymerase chain reaction optimized for clinical use in a commercial setting. The company was founded in 1998 and is headquartered in Boulder, CO. | Corporate Officer/Principal | 01/01/1998 | - |
Training of Danute M. Bankaitis-Davis
| The University of North Carolina at Charlotte | Doctorate Degree |
| Cleveland State University | Graduate Degree |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
Source Precision Medicine, Inc.
Source Precision Medicine, Inc. Medical SpecialtiesHealth Technology Source Precision Medicine, Inc. develops and commercializes diagnostic biomarker panels. It develops an integrated molecular diagnostic system, which includes quantitative polymerase chain reaction assays, target specific gene expression ranges, and latent class and proprietary enumeration methodologies that measure vital signs of the cell. Its assays and tests measure RNA-transcript-based gene expression in whole blood using quantitative polymerase chain reaction optimized for clinical use in a commercial setting. The company was founded in 1998 and is headquartered in Boulder, CO. | Health Technology |
| Syntex Corp. | Health Technology |
